5041 - 5050 of 6509 Results
Title
Year
-
OPENTitle: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 771End Page: 782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27361Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27361Citation Count: 203
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 139
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 78
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 194
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 39
-
OPENTitle: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative studyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 6Start Page: 935End Page: 949Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/40503Citation Count: 216
-
OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 8
-
OPENTitle: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is PresentJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 157End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14802/jmd.20159Best OA location URL: https://doi.org/10.14802/jmd.20159Citation Count: 10
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 48
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 87